Immunohistochemical analysis of 120 patients with lung adenocarcinoma demonstrated that CaSR expression was significantly increased in lung cancer tissues of lung adenocarcinoma patients with bone metastases compared to patients without. This evidence concerns the gene CASR and lung adenocarcinoma.